Skip to main content
Livermore
Livermore
ZHEN

Birchview Capital, LP

SEC CIK
0001618205
Latest filing
Aug 14, 2026

NBIX holding history

Neurocrine Biosciences Inc in every 13F filed by Birchview Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NBIX overviewAll 13F holders of NBIXFull Q2 2026 holdings

Shares (Q2 2026)
27,190
Value
$4.58M
% of portfolio
2.1%
Quarters held
22
Since Q1 2021
Holdings of NBIX by Birchview Capital, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202627,190$4.58M2.1%00.0%UnchangedHolders
Q1 202627,190$3.58M2.0%00.0%UnchangedHolders
Q4 202527,190$3.86M2.3%−1,500−5.2%ReducedHolders
Q3 202528,690$4.03M3.0%−2,250−7.3%ReducedHolders
Q2 202530,940$3.89M3.9%+700+2.3%AddedHolders
Q1 202530,240$3.34M2.9%00.0%UnchangedHolders
Q4 202430,240$4.13M3.4%00.0%UnchangedHolders
Q3 202430,240$3.48M3.0%−12,000−28.4%ReducedHolders
Q2 202442,240$5.82M5.4%−35,000−45.3%ReducedHolders
Q1 202477,240$10.7M8.7%00.0%UnchangedHolders
Q4 202377,240$10.2M8.0%00.0%UnchangedHolders
Q3 202377,240$8.69M7.4%−7,000−8.3%ReducedHolders
Q2 202384,240$7.94M6.0%00.0%UnchangedHolders
Q1 202384,240$8.53M6.7%00.0%UnchangedHolders
Q4 202284,240$10.1M7.1%−1,000−1.2%ReducedHolders
Q3 202285,240$9.05M6.4%00.0%UnchangedHolders
Q2 202285,240$8.31M6.0%−4,000−4.5%ReducedHolders
Q1 202289,240$8.37M6.0%+400.0%AddedHolders
Q4 202189,200$7.60M4.9%+9,000+11.2%AddedHolders
Q3 202180,200$7.69M5.2%00.0%UnchangedHolders
Q2 202180,200$7.80M4.7%00.0%UnchangedHolders
Q1 202180,200$7.80M4.6%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.